Chlorproguanil-Dapsone-Artesunate Versus COARTEM For Uncomplicated Malaria

Clinical trial NCT00344006 · COMPLETED

Trial details

NCT number: NCT00344006
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Malaria, Falciparum

Start date: 2006-06-01
Primary completion: 2007-08-01
Enrollment: 1395

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.